Multicenter phase 1/2 application of adenovirus-specific T cells in high-risk pediatric patients after allogeneic stem cell transplantation
ConclusionThe study demonstrates the safety and feasibility of pre-emptively manufacturing peptide pulsed ADV-specific cells for high-risk pediatric patients after transplantation and provides early evidence of clinical efficacy.
Source: Cytotherapy - Category: Cytology Source Type: research
More News: Adenoviruses | Astrovirus | Children | Cytology | Encephalitis | Pancreatitis | Pediatrics | Stem Cell Therapy | Stem Cells | Study | Transplants | UK Health